mr 2034 has been researched along with morphiceptin in 1 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (morphiceptin) | Trials (morphiceptin) | Recent Studies (post-2010) (morphiceptin) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 139 | 0 | 12 |
| Protein | Taxonomy | mr 2034 (IC50) | morphiceptin (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0566 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.32 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geppert, M; Illes, P; Jackisch, R | 1 |
1 other study(ies) available for mr 2034 and morphiceptin
| Article | Year |
|---|---|
Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
Topics: Animals; Benzomorphans; Clonidine; Cyclazocine; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Enkephalins; Ethylketocyclazocine; Hippocampus; Morphine; Norepinephrine; Rabbits; Receptors, Opioid | 1986 |